Amarnath Challapalli

6PUBLICATIONS
24CO-AUTHORS
Applications in healthOncology and carcinogenesis not elsewhere classifiedPharmaceutical delivery technologiesCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 02, 2024
Is the digital rectal exam any good as a prostate cancer screening test?

Mike Kirby, Samuel Wd Merriel, Oluwabunmi Olajide

|Jul 04, 2024
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts.

C Gaudy-Marqueste, J J Grob, C Garbe

|May 11, 2024
Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands.

Mitesh Naik, Sairah R Khan, Valerie Lewington

|Dec 23, 2023
Bench to Bedside Development of [<sup>18</sup>F]Fluoromethyl-(1,2-<sup>2</sup>H<sub>4</sub>)choline ([<sup>18</sup>F]D4-FCH).

Amarnath Challapalli, Tara D Barwick, Suraiya R Dubash

|Mar 17, 2022
Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme.

A Challapalli, S Watkins, G Cogill

|Sep 11, 2019
A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis.

Amarnath Challapalli, Sylvia Pearson, Anita V Mitra

Pageof 1